INTRODUCTION
Anesthesiologists are often expected to provide safe, smooth and effective anesthesia. The ideal agent for this should have greater margin of safety in all age groups, also have quick onset and offset with the target outcome being an adequate level of anesthesia, analgesia, sedation, minimal anxiety, maximal amnesia, minimal drug related adverse effect while maintaining cardiovascular respiratory stability. 1, 2 Currently no Indi dual agent is available which encompasses this aim, with the use of propofol and ketamine mixture the undesired effect of both decreases. 3 Propofol is sedative hypnotic agent with a short onset duration and recovery time. 4 This property makes propofol an ideal agent for anesthesia but can cause cardio respiratory instability and depression at the doses needed for laryngeal mask insertion. 5, 6, 7 The ketamine stimulate sympathetic nervous system and increases blood pressure along with increasing the heart rate. It has been reported that intra operative hemodynamic is more stable in studies where propofol and ketamine were combined. 8, 9 The hypothesis of the study is to compare the combination of two drugs namely propofol and ketamine (ketofol) in various concentration to achieve desired end point, their effect on hemodynamic and laryngeal mask insertion condition.
METHODS
A 100 patients of ASA class I, II scheduled for elective surgery that was last up to for two hours, between 18-65 years of either sex were included in the study during July 2017-June 2018. After approval from local research ethical committee written informed consent was obtained from patients. Patients with increased aspiration risk, body mass index >30, allergy to any agent used in study, predicted difficult airway, mallampati <2, patients with clinically significant cardio respiratory, psychiatric illness were excluded from study. Patients premedicated with Iv Glycopyrrolate 0.004 mg/kg, Iv Midazolam 0.02mg /kg, Iv Fentanyl 1-2 µg/kg followed by Iv ketofol mixture 0f 1:1,1:2,1:3,1:4 ratio as decided for various group, at 10 ml/60 sec till loss of consciousness was achieved. The anesthesiologist who prepared the ketofol mixture of different concentration was no more part of study further.
Laryngeal mask airway with deflated cuff was inserted by an experienced anesthetist using a water-soluble lubricant as per guideline of manufacturer 60 second after induction. If patient remains apneic for more than 30 seconds patient ventilation was assisted manually with bag and mass. LMA size 3 for patients ≤155 cm, size 4 for 155-180 cm and size 5 for ≥180 cm was used.
A cuff was inflated with proposed amount of air using injector. Effective ventilation was confirmed by capnography and chest expansion. A maximum 3 attempts were allowed for insertion of LMA, scoring was done for 1st attempt only.
If LMA could not be inserted in 3 attempts than alternative airway device was used. After successful placement of LMA anesthesia was maintained with isoflurane 1.5-2 % dial concentration, 50 % of N 2 O and 50 % O 2 was used following LMA insertion patients were manually ventilated until spontaneous respiration was returned, and this period was recorded as apnea time.
Later on, patients were paralyzed and ventilated with synchronized intermittent mandatory ventilation mode until end of operation followed by reversal in usual manner. Condition of insertion of LMA were assessed using 6 variable mouth opening (1-full, 2-partial and 3-none), swallowing (1-nil, 2-mild and 3-severe), laryngospasm (1-nil, 2-mild, and 3-severe) and ease of LMA insertion (1-easy, 2-difficult and 3-impossible). Cessation of respiration for 30 sec was accepted as apnea and apnea time was recorded. Number of attempts for successful LMA insertion time was also noted.
RESULTS
Hundred patients were studied in this prospective randomized trial. They were divided into 4 groups, they are Group A (26 patients), Group B (25 patients), Group C (25 patients) and Group D (24 patients). Out of 100 52 were male and 48 were female patients.
Demographic data including age, weight, height and BMI were depicted in Table1, have no significant difference among them. The mean age was 37.515. Values are presented as mean ± SD or numbers of patient Hemodynamic parameter included pulse rate, systolic blood pressure, diastolic blood pressure and mean blood pressure have shown in Table 3 . Pulse rate was low at T1 time (before induction) in Group D, when compared to group A, B and C, was statistically significant (P-0.03), (Table 1) . At T2 time pulse rate was comparable in all groups. At T2 time the pulse rate was 77.332.69 in Group D, it was lowest among all 4 Groups as depicted in Table 3 . Mean BP was comparable in all 4 groups. Among insertion criteria 2 patients in Group1 and 1 patient in Group2 presented with grade II mouth opening, rest all the patients have shown grade I mouth opening as shown in Table 2 . None of the patients among 100 had coughed after induction. 4 Patients in Group A and in Group D showed neck and body movements. LMA insertion could not be done in 2 patients of Group B while it was difficult in 3 patients of group A and 2 patients of Group C. All the patients of Group D had easy insertion of LMA as depicted in Table 2 . None of the patients had undergone laryngospasm after induction (Table 2) . Apnea time, and LMA insertion time is depicted in Table 4 , it shows that apnea time was longest in Group A and was statistically significant (P-0.002). The patients of Group C and Group D took less time in LMA insertion comparing to Group A and B. It was statistically significant as shown in Table 4 . 
DISCUSSION
There is no real standard dosing regimen establish to prepare ketofol, most studies had conducted with 1:1 ratio comparing with either of propofol, katamine. 10 This study has planned to compare effect of various combinations of ketamine-propofol (ketofol) on hemodynamic and LMA insertion condition. While comparing hemodynamic parameter including heart rate systolic, diastolic and mean BP among inter and intra group, heart rate at T3 time (Table 3) found lowest in group D it suggests that propofol causes dose dependent cardiac depression. 11, 5 Propofol concentration in ketofol mixture is continuously increasing from A to D group. Diastolic BP shows statistically significant difference at T2 times (p-0.04), is high in group A (Table 3) suggesting cardio protective action of ketamine and group D showed lowest diastolic BP as containing highest propofol fraction (1:4) in mixture (p-0.04). Group A that contained high fraction of ketamine showed high DBP. Gupta et al who compared ketamine, fentanyl and butorphanol before propofol induction in LMA insertion found higher systolic and diastolic BP in ketamine group. 12 These findings are also supported by Goh et al who compared ketamine, fentanyl or saline during LMA insertion prior to propofol induction. 13 In the present study it has been observed that apnea duration was highest in group A.
It was statistically significant (p -0.002). It has been shown in various animals and human studies that bolus dose of ketamine depresses the respiratory response to CO 2 , similar to opioid. Similarly, there are studies stating that hypoxemia and apnea have been observed following I.V. administration of katamine. 14, 15 In this study group A having highest fraction of ketamine in ketofol so the blood level of ketamine rises rapidly. LMA insertion time was significantly (p-0.0089) less in groups C and D comparing group A and B. Ketamine produces increase in muscle tone some time spasm. In groups C and D higher concentration of propofol suppresses this effect and made LMA insertion easy.
CONCLUSION
Addition of low dose of ketamine with propofol makes LMA insertion easier comparing to addition of higher dose of ketamine with propofol. Apnea duration and LMA insertion time is longer when ketamine is added in 1:1 and 1:2 ratio in ketofol mixture. Addition of small dose of ketamine to propofol favors LMA insertion. Further studies with larger study population are needed to get the more information.
